Alaska Hospitalist Group Llc | |
4300 B Street Suite 200 Anchorage AK 99503 | |
(907) 375-3355 | |
(907) 375-3351 |
Full Name | Alaska Hospitalist Group Llc |
---|---|
Speciality | Internal Medicine |
Location | 4300 B Street, Anchorage, Alaska |
Authorized Official Name and Position | Jocelyn Pemberton (CEO) |
Authorized Official Contact | 9073753355 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Alaska Hospitalist Group Llc 4300 B Street Suite 200 Anchorage AK 99503 Ph: (907) 375-3355 | Alaska Hospitalist Group Llc 4300 B Street Suite 200 Anchorage AK 99503 Ph: (907) 375-3355 |
NPI Number | 1831296995 |
---|---|
Provider Enumeration Date | 09/20/2006 |
Last Update Date | 10/24/2018 |
Medicare PECOS PAC ID | 6507755964 |
---|---|
Medicare Enrollment ID | O20040312001148 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1831296995 | NPI | - | NPPES |
MDG421 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (* (Not Available)) | Primary |
207RC0200X | Internal Medicine - Critical Care Medicine | (* (Not Available)) | Secondary |
Provider Name | Patrick D Brady |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1982772505 PECOS PAC ID: 3274437793 Enrollment ID: I20031125000518 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Matthew C Berenson |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1588633150 PECOS PAC ID: 0446158158 Enrollment ID: I20031219000337 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Jeffrey J Mcdonald |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1821034869 PECOS PAC ID: 5991693889 Enrollment ID: I20040310001181 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Christine Kramer |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1942220108 PECOS PAC ID: 4688565807 Enrollment ID: I20040324001226 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | John Paul Bramante |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1336185081 PECOS PAC ID: 5698663573 Enrollment ID: I20040415000313 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Chris Devon Zerger |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1477579571 PECOS PAC ID: 9830184829 Enrollment ID: I20040419000894 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | John C Boston |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1982666137 PECOS PAC ID: 8123017761 Enrollment ID: I20040510000659 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Bennett H Lee |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1548368673 PECOS PAC ID: 3476534298 Enrollment ID: I20040527000613 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Terry L Lester |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1891893921 PECOS PAC ID: 0244214013 Enrollment ID: I20040716000459 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Ryan M Mcghan |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1417986274 PECOS PAC ID: 8022080167 Enrollment ID: I20040810000604 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Keith B Augustin |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1679671796 PECOS PAC ID: 8820076698 Enrollment ID: I20041103001286 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Elizabeth Martinez Augustin |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1487772810 PECOS PAC ID: 8123071370 Enrollment ID: I20050228000619 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Michael M Mraz |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1629011218 PECOS PAC ID: 0547201659 Enrollment ID: I20050519000219 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Ronald L Healy |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1144329145 PECOS PAC ID: 5193762128 Enrollment ID: I20050823001158 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Matthew J Magruder |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1831271477 PECOS PAC ID: 4486679370 Enrollment ID: I20051010000889 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Mark E Agnew |
---|---|
Provider Type | Practitioner - Geriatric Medicine |
Provider Identifiers | NPI Number: 1992898704 PECOS PAC ID: 4587686217 Enrollment ID: I20051222000188 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Emily C Church |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1477536316 PECOS PAC ID: 5597863803 Enrollment ID: I20070611000473 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Shari D Morgan |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1649215419 PECOS PAC ID: 2163520487 Enrollment ID: I20070611000541 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Javid Kamali |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1306985346 PECOS PAC ID: 9537252531 Enrollment ID: I20070907000177 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Matthew J Dudley |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1427155423 PECOS PAC ID: 9133212863 Enrollment ID: I20070911000396 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Katherine N Naylor |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1013938729 PECOS PAC ID: 6305840356 Enrollment ID: I20071116000390 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Anthony K Larson |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1053418004 PECOS PAC ID: 7517057193 Enrollment ID: I20071219000671 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Crystal J Imperato |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1871708297 PECOS PAC ID: 3577646348 Enrollment ID: I20080218000070 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Robert D Church |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1336246396 PECOS PAC ID: 9537234869 Enrollment ID: I20080820000440 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Sharolyn H Baldwin |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1649325127 PECOS PAC ID: 2264595685 Enrollment ID: I20090112000584 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Alexis Delgado |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1033146709 PECOS PAC ID: 1456354851 Enrollment ID: I20090112000666 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Jeffrey Melendez |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1801914023 PECOS PAC ID: 8123119229 Enrollment ID: I20090423000072 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Julian T Rojas |
---|---|
Provider Type | Practitioner - Pulmonary Disease |
Provider Identifiers | NPI Number: 1982814208 PECOS PAC ID: 5092866483 Enrollment ID: I20090624000653 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Lior Dolgonos |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1710033311 PECOS PAC ID: 2163522996 Enrollment ID: I20090818000866 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Dustin M Lang |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1871649558 PECOS PAC ID: 1254478217 Enrollment ID: I20091022000752 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Karen Mailer |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1346254307 PECOS PAC ID: 0547288441 Enrollment ID: I20091201000687 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Jose L Luna Zelaya |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1194964239 PECOS PAC ID: 0244372118 Enrollment ID: I20100115000454 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Kristin M Mitchell |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1023054061 PECOS PAC ID: 4587552468 Enrollment ID: I20100312000439 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Mandy R Garnett |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1639376924 PECOS PAC ID: 5698890515 Enrollment ID: I20100916000037 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Shadi I Battah |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1851412340 PECOS PAC ID: 6204951908 Enrollment ID: I20100918000064 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Michael L Smith |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1942428354 PECOS PAC ID: 2860684438 Enrollment ID: I20101014000663 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Timothy Bateman |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1285732305 PECOS PAC ID: 6305735762 Enrollment ID: I20110103000937 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | George P Spady |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1881701407 PECOS PAC ID: 3779532387 Enrollment ID: I20110107000568 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Dorothy M Shearn |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1275633091 PECOS PAC ID: 2860381225 Enrollment ID: I20110111000793 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Michael G Mullowney |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1578662391 PECOS PAC ID: 2668434333 Enrollment ID: I20110121000448 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Joseph R Lestina |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1144328279 PECOS PAC ID: 4486543840 Enrollment ID: I20110121000477 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Shannon Lynn Yoder |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1770887101 PECOS PAC ID: 9335320589 Enrollment ID: I20110222000671 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Chris A Swanson |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1134379159 PECOS PAC ID: 4385814128 Enrollment ID: I20110902000403 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Leslie Gonsette |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1891978599 PECOS PAC ID: 2961535851 Enrollment ID: I20111011000280 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Kristen Marie Lee |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1982894861 PECOS PAC ID: 8729272703 Enrollment ID: I20120119000842 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Larry S Owen |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1396859666 PECOS PAC ID: 1355399858 Enrollment ID: I20130212000295 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Michael R Alcorn |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1760547210 PECOS PAC ID: 0840430898 Enrollment ID: I20130716000015 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Gail Michelle Pokorney |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1588980445 PECOS PAC ID: 2264674308 Enrollment ID: I20130820000327 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Aaron Haynes |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1821271677 PECOS PAC ID: 2466636188 Enrollment ID: I20130927000277 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | David L Grills |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1447418132 PECOS PAC ID: 2264603216 Enrollment ID: I20130927000328 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Edwin Lee |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1710148705 PECOS PAC ID: 0648311761 Enrollment ID: I20131203000531 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Shannon C Hilton |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1265787204 PECOS PAC ID: 7214167394 Enrollment ID: I20140312000099 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Jonathan Daining |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1215195755 PECOS PAC ID: 6507034972 Enrollment ID: I20140605001646 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Brian Jeppesen |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1760773436 PECOS PAC ID: 1254576168 Enrollment ID: I20140719000022 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Ido Barkay |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1568751477 PECOS PAC ID: 3476799735 Enrollment ID: I20140813000908 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Joseph V Pace |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1982693586 PECOS PAC ID: 2062632698 Enrollment ID: I20141002002383 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Susan Hayner |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1487933297 PECOS PAC ID: 3779737135 Enrollment ID: I20141021002614 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Will A Bemben |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1891082699 PECOS PAC ID: 7113170028 Enrollment ID: I20141030002049 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Mark Hansen |
---|---|
Provider Type | Practitioner - Pulmonary Disease |
Provider Identifiers | NPI Number: 1851566947 PECOS PAC ID: 7315091212 Enrollment ID: I20150506001407 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Ailinh Tran |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1306172853 PECOS PAC ID: 3476728833 Enrollment ID: I20150708002334 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Tokunbo James Matthews |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1205994852 PECOS PAC ID: 7012167786 Enrollment ID: I20150722006544 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Nicholas Flickinger |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1740544097 PECOS PAC ID: 5395999742 Enrollment ID: I20150803002849 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Robert Finch |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1811250319 PECOS PAC ID: 2466767207 Enrollment ID: I20150821014670 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Ryan G Webb |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1770808586 PECOS PAC ID: 0941523104 Enrollment ID: I20151015002280 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Amar S Kapur |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1295020683 PECOS PAC ID: 3779701719 Enrollment ID: I20151023002064 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Cody M Augdahl |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1801150974 PECOS PAC ID: 3971756438 Enrollment ID: I20151216002600 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Ruth A Dukoff |
---|---|
Provider Type | Practitioner - Psychiatry |
Provider Identifiers | NPI Number: 1760495246 PECOS PAC ID: 1153319330 Enrollment ID: I20160509002423 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Lucinda A. Macneal |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1366678641 PECOS PAC ID: 3971736182 Enrollment ID: I20160726003051 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | David S Wenger |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1386919686 PECOS PAC ID: 8921322967 Enrollment ID: I20160803001523 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Kathryn A Ryan |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1629418215 PECOS PAC ID: 4385873249 Enrollment ID: I20161031000476 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Terin Ostroski |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1154663680 PECOS PAC ID: 9830316660 Enrollment ID: I20161129000162 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Ravinder P Shergill |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1053341099 PECOS PAC ID: 9830095017 Enrollment ID: I20170109002966 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Blair Curtis |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1831481514 PECOS PAC ID: 4981848439 Enrollment ID: I20170117000451 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Nicholas P Cosentino |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1013276898 PECOS PAC ID: 1456675099 Enrollment ID: I20170419001752 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | George N Ntui-ayuk |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1760796775 PECOS PAC ID: 7719134386 Enrollment ID: I20170424002391 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | David B Penn |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1477968485 PECOS PAC ID: 9234354382 Enrollment ID: I20170728002203 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Lindsay Rumberger-rivera |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1235440843 PECOS PAC ID: 0749422269 Enrollment ID: I20170829000342 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Toby Currin |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1720493737 PECOS PAC ID: 4284859430 Enrollment ID: I20180116001344 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Anna E Reese |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1295761500 PECOS PAC ID: 8022033992 Enrollment ID: I20180518001744 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Katherine Hope Buddenberg |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1336374875 PECOS PAC ID: 7214163203 Enrollment ID: I20180712000626 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Calvin B Davis |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1386023596 PECOS PAC ID: 5496068546 Enrollment ID: I20180801001243 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Casey S Mapes |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1083009906 PECOS PAC ID: 4183930589 Enrollment ID: I20180821000675 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Eric Dreibelbeis |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1518371210 PECOS PAC ID: 2264650878 Enrollment ID: I20180821004177 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | David M Abel |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1598151797 PECOS PAC ID: 6507170792 Enrollment ID: I20180905003277 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Katherine Alice Senter |
---|---|
Provider Type | Practitioner - General Surgery |
Provider Identifiers | NPI Number: 1134474810 PECOS PAC ID: 8527323476 Enrollment ID: I20181016004101 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Elizabeth Hankinson |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1538452941 PECOS PAC ID: 0244546877 Enrollment ID: I20181026001994 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Brian W Newman |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1649631193 PECOS PAC ID: 6406154681 Enrollment ID: I20181116000060 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Christopher J Beaudoin |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1710306410 PECOS PAC ID: 5991095382 Enrollment ID: I20190318001049 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Erin Alaina Reding |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1588133748 PECOS PAC ID: 7012257629 Enrollment ID: I20190319000148 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Alicia Blenkush |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1407374309 PECOS PAC ID: 2062753858 Enrollment ID: I20190403003217 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Charles L Wilson |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1063838639 PECOS PAC ID: 6305118514 Enrollment ID: I20190426002227 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Syed Mushfiqur Rahman |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1497140131 PECOS PAC ID: 2264775576 Enrollment ID: I20190529002079 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Sergei Robinson |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1740672708 PECOS PAC ID: 6002120854 Enrollment ID: I20190614000887 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Susan Lynn Davis |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1902342520 PECOS PAC ID: 3375811490 Enrollment ID: I20190628001442 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Julia Herbert |
---|---|
Provider Type | Practitioner - Hospice/palliative Care |
Provider Identifiers | NPI Number: 1245625128 PECOS PAC ID: 6002144359 Enrollment ID: I20190823001775 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Andrew Timothy Ingram |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1164499216 PECOS PAC ID: 2769519560 Enrollment ID: I20190910002273 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Megan U Roosen-runge |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1245624204 PECOS PAC ID: 1658682331 Enrollment ID: I20191122001078 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Louis J Bartoletti |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1790133239 PECOS PAC ID: 0345533196 Enrollment ID: I20200106002856 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Emma Coleman |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1780078758 PECOS PAC ID: 9638471931 Enrollment ID: I20200207002316 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Shasta M Stephens |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1417312315 PECOS PAC ID: 1254638828 Enrollment ID: I20200528000778 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Elizabeth L Ohlsen |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1093249427 PECOS PAC ID: 8527337757 Enrollment ID: I20200701003465 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Jon Grace |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1245573278 PECOS PAC ID: 8527286046 Enrollment ID: I20200706000972 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Daniel Hyman |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1922493675 PECOS PAC ID: 8123454337 Enrollment ID: I20200714002557 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Erik K Hauswald |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1760919377 PECOS PAC ID: 3577832708 Enrollment ID: I20200715000988 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Matthew Paul Strohmeyer |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1457883266 PECOS PAC ID: 8628492030 Enrollment ID: I20200717002541 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Nataliya V Polito |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1306259361 PECOS PAC ID: 3971922014 Enrollment ID: I20200923001922 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Angene V Johnson |
---|---|
Provider Type | Practitioner - Geriatric Medicine |
Provider Identifiers | NPI Number: 1134581226 PECOS PAC ID: 9436441342 Enrollment ID: I20210210003293 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Kala Maus |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1699264903 PECOS PAC ID: 3971851510 Enrollment ID: I20210615003463 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Hans J Wilhelm |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1467941674 PECOS PAC ID: 5799033460 Enrollment ID: I20210618001226 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Benjamin Walz |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1407098577 PECOS PAC ID: 7214176635 Enrollment ID: I20210629000000 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Elizabeth Clare Cummings |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1023514650 PECOS PAC ID: 8921401928 Enrollment ID: I20210728003402 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Isaac Saul Lopez |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1831694785 PECOS PAC ID: 8628471638 Enrollment ID: I20210728004135 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Michael Walleri |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1295224400 PECOS PAC ID: 0446508113 Enrollment ID: I20210830002444 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Catherine Anne Marzan |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1568902997 PECOS PAC ID: 5890020804 Enrollment ID: I20220906001285 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Claire Enriquez |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1194384891 PECOS PAC ID: 5193109478 Enrollment ID: I20220906001758 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Stephen Ellison |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1134782121 PECOS PAC ID: 8729314059 Enrollment ID: I20220907002854 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Dustin J Mclemore |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1427218601 PECOS PAC ID: 8224255799 Enrollment ID: I20230306002299 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Tushar Garg |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1184104218 PECOS PAC ID: 8325475775 Enrollment ID: I20230713001738 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Matthew Evans |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1295399590 PECOS PAC ID: 7315360989 Enrollment ID: I20230801001175 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Alexandra Davis |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1366063349 PECOS PAC ID: 1355764424 Enrollment ID: I20230802002982 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Andrew R Edwards |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1629697396 PECOS PAC ID: 4587087093 Enrollment ID: I20230821001314 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Heath Wade Turner |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1235768094 PECOS PAC ID: 9537582523 Enrollment ID: I20230823002552 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Kathleen Gardner Judd |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1477013159 PECOS PAC ID: 3678808391 Enrollment ID: I20230824003300 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Emma Simpson |
---|---|
Provider Type | Practitioner - Critical Care (intensivists) |
Provider Identifiers | NPI Number: 1396122412 PECOS PAC ID: 5698187037 Enrollment ID: I20230927003600 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Kyler Benjamin Dykes |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1720616428 PECOS PAC ID: 8325479710 Enrollment ID: I20230928001808 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Carol Ann Sant |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1275214520 PECOS PAC ID: 8224483656 Enrollment ID: I20231004003891 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Provider Name | Olivia Roehling |
---|---|
Provider Type | Practitioner - Hospitalist |
Provider Identifiers | NPI Number: 1285262246 PECOS PAC ID: 8527499128 Enrollment ID: I20231208001875 |
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
News Archive
A study by researchers at the University of Chicago Medicine shows that when mice that are genetically susceptible to developing inflammatory bowel disease (IBD) were given antibiotics during late pregnancy and the early nursing period, their offspring were more likely to develop an inflammatory condition of the colon that resembles human IBD.
Researchers from the U.S. and Sweden have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. They suggest that these findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help physicians assess the long-term risk faced by newly diagnosed prostate cancer patients.
Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/245,607 ("the '607 Application").
Globally, the burden of neurological disorders (Alzheimer's disease, Parkinson's disease, stroke, epilepsy etc) has increased substantially over the past 25 years.
Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK's Westfield London – Europe's largest shopping centre.
› Verified 9 days ago
Alaska Premier Health Alaska Sports Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3300 Arctic Blvd, 101, Anchorage, AK 99503 Phone: 907-561-3488 Fax: 907-562-3488 | |
Alaska Family Care Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4001 Dale Street, Suite 210, Anchorage, AK 99508 Phone: 907-929-5888 Fax: 907-929-5882 | |
Daryl M. Mcclendon, M.d., P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3851 Piper St, Suite U466, Anchorage, AK 99508 Phone: 907-569-1333 Fax: 907-569-1433 | |
Willow Wellness Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3030 Wendys Way Unit A, Anchorage, AK 99517 Phone: 406-253-7924 | |
Douglas Carter Smith, Md Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 17741 Mountainside Village Dr, Anchorage, AK 99516 Phone: 907-345-0728 Fax: 907-345-0728 | |
Internal Medicine Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2841 Debarr Rd Ste 50, Anchorage, AK 99508 Phone: 907-276-2811 Fax: 907-276-2810 | |
Summit Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2741 Debarr Rd, Suite C308, Anchorage, AK 99508 Phone: 907-272-3366 Fax: 907-272-0269 |